Because BAs are critical regulators of fat absorption and hepatic lipid and glucose metabolism, it is rational to consider that BA and BA-related molecules (e.g., FXR, TGR5, FGF19) contribute to microbiota-associated protection against NAFLD. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.